KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing information about a medication that has
completed Phase III clinical trials. Which statement best
describes the purpose of this phase of drug development?
A. It evaluates basic pharmacologic activity in laboratory models
only.
B. It determines safety, effectiveness, and common adverse
effects in a large population before potential regulatory
approval.
C. It monitors rare adverse reactions after the drug is marketed.
D. It establishes manufacturing standards without evaluating
clinical outcomes.
Correct Answer: B
Rationale:
Phase III clinical trials involve large groups of participants and
are designed to confirm therapeutic effectiveness, identify
common adverse effects, compare the medication with existing
therapies when appropriate, and provide data for regulatory
review. Option A describes preclinical testing. Option C refers to
post-marketing (Phase IV) surveillance. Option D addresses
manufacturing quality but is not the primary purpose of Phase
III trials.
,Question 2
A patient asks why a newly prescribed medication requires
regular laboratory monitoring even though it has been
approved for use. Which response by the nurse is most
appropriate?
A. "Approved medications never cause unexpected adverse
effects."
B. "Laboratory monitoring helps detect therapeutic response
and identifies potential toxicity before serious harm occurs."
C. "The laboratory tests are only required because the
medication is expensive."
D. "Monitoring is performed only for research purposes."
Correct Answer: B
Rationale:
Many medications require laboratory monitoring to evaluate
therapeutic effectiveness, organ function, and potential toxicity.
Early detection of adverse effects promotes patient safety.
Approved medications can still produce adverse reactions,
making Option A incorrect. Cost is not the primary reason for
monitoring (Option C), and laboratory monitoring in routine
care is not performed solely for research (Option D).
Question 3
, A nurse is teaching a patient about the difference between a
medication's therapeutic effect and its adverse effects. Which
statement demonstrates correct understanding?
A. "Therapeutic effects are the intended beneficial responses,
while adverse effects are unintended harmful responses."
B. "Adverse effects occur only when the wrong dose is
prescribed."
C. "Therapeutic effects occur only after several years of
treatment."
D. "All adverse effects are considered allergic reactions."
Correct Answer: A
Rationale:
Therapeutic effects are the desired clinical outcomes of
medication therapy. Adverse effects are unintended and
potentially harmful responses that may occur even when the
medication is used correctly. Option B is incorrect because
adverse effects may occur at therapeutic doses. Option C is
inaccurate because therapeutic effects may occur immediately
or over time depending on the medication. Option D is incorrect
because allergic reactions represent only one type of adverse
effect.
Question 4
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing information about a medication that has
completed Phase III clinical trials. Which statement best
describes the purpose of this phase of drug development?
A. It evaluates basic pharmacologic activity in laboratory models
only.
B. It determines safety, effectiveness, and common adverse
effects in a large population before potential regulatory
approval.
C. It monitors rare adverse reactions after the drug is marketed.
D. It establishes manufacturing standards without evaluating
clinical outcomes.
Correct Answer: B
Rationale:
Phase III clinical trials involve large groups of participants and
are designed to confirm therapeutic effectiveness, identify
common adverse effects, compare the medication with existing
therapies when appropriate, and provide data for regulatory
review. Option A describes preclinical testing. Option C refers to
post-marketing (Phase IV) surveillance. Option D addresses
manufacturing quality but is not the primary purpose of Phase
III trials.
,Question 2
A patient asks why a newly prescribed medication requires
regular laboratory monitoring even though it has been
approved for use. Which response by the nurse is most
appropriate?
A. "Approved medications never cause unexpected adverse
effects."
B. "Laboratory monitoring helps detect therapeutic response
and identifies potential toxicity before serious harm occurs."
C. "The laboratory tests are only required because the
medication is expensive."
D. "Monitoring is performed only for research purposes."
Correct Answer: B
Rationale:
Many medications require laboratory monitoring to evaluate
therapeutic effectiveness, organ function, and potential toxicity.
Early detection of adverse effects promotes patient safety.
Approved medications can still produce adverse reactions,
making Option A incorrect. Cost is not the primary reason for
monitoring (Option C), and laboratory monitoring in routine
care is not performed solely for research (Option D).
Question 3
, A nurse is teaching a patient about the difference between a
medication's therapeutic effect and its adverse effects. Which
statement demonstrates correct understanding?
A. "Therapeutic effects are the intended beneficial responses,
while adverse effects are unintended harmful responses."
B. "Adverse effects occur only when the wrong dose is
prescribed."
C. "Therapeutic effects occur only after several years of
treatment."
D. "All adverse effects are considered allergic reactions."
Correct Answer: A
Rationale:
Therapeutic effects are the desired clinical outcomes of
medication therapy. Adverse effects are unintended and
potentially harmful responses that may occur even when the
medication is used correctly. Option B is incorrect because
adverse effects may occur at therapeutic doses. Option C is
inaccurate because therapeutic effects may occur immediately
or over time depending on the medication. Option D is incorrect
because allergic reactions represent only one type of adverse
effect.
Question 4
